University Hospital, Grenoble

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

164

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

4 drugs in development

Approved1

Phase 32

Phase 21

Phase 11

Preclinical1

By Therapeutic Area

top 2

Respiratory

120%

Cardiovascular

120%

R&D Momentum

82/100

Pipeline Velocity

59/100

Trial Completion Rate

71/100

Pipeline Concentration

44/100

Pipeline Freshness

62/100

Strategic Signals

↗Active in Respiratory but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Oct 27, 2026

Completed

Pulsed Field Ablation vs Cryoablation In Paroxysmal Atrial Fibrillation

Oct 27, 2026

Completed

New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.

Oct 24, 2026

Recruiting

Methodological Study of Exercise and Hypoxic Conditions in Healthy Subjects

Earlier

Oct 21, 2026TrialTranscranial Ultrasonography for the Management of Patients With Mild Traumatic Brain Injury

Oct 21, 2026TrialEffecT of eARly analGesia With Erector Spinae Plane Block to Reduce Ventilation After Severe Chest Trauma: a Randomised Control Open-label Trial.

Oct 16, 2026TrialAutomated and Reliable Estimation of Patient Height From CT Scan Using an Artificial Intelligence Algorithm - Automated Height Estimation by Artificial Intelligence

Oct 14, 2026TrialVisio-consultation Compared to Face-to-face Consultation During the Follow-up of Apneic Patients Treated by Continuous Positive Airway Pressure (CPAP)

Oct 14, 2026TrialStudy of Three Endpoints to Assess the Benefit of Rehabilitation in Patients With Advanced Non-small Cell Lung Cancer Controlled After at Least 6 Months of Systemic Treatment

4 more events

Oct 7, 2026TrialTechnical Feasibility Study of Ultrasound Muscle Imaging in Antenatal Ultrasound Screening of Congenital Multiple Arthrogryposis

Oct 6, 2026TrialStudy on the Management of COMISA

Oct 3, 2026TrialLAnguage-Motor Imagery Circuits to Improve Motor Learning and Language Comprehension

Oct 3, 2026TrialDevelopment of MRI Protocols and Associated Neuro-physiological Explorations in Healthy and Pathological Subjects

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

AvinzaPhase 2

Interstitial Lung Disease

AvinzaApproved

Unknown / Other

Brain Death

Volatile anestheticPhase 3

Cesarean Section

AvinzaPreclinical

Sedation

Propofol-LipuroPhase 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)